Deal record
Blackstone, Carlyle, and Hellman & Friedman acquire a majority stake in Medline Industries
Leveraged buyout · Recorded status: Completed
Verified findings
Facts and causal attributions that have passed evidence review and remain backed by their reviewed sources.
No verified findings published yet.
Last reviewed: Unknown · Record updated: Sept. 2, 2026
Recorded deal
Database fields for this transaction. A recorded status is not an independently verified closing fact, and a recorded date or value is not a verified one.
- Transaction type
- Leveraged buyout
- Recorded status
- Completed
- Announced
- June 5, 2021
- Closed
- Unknown
- Recorded value
- approximately $34 billion
- Ownership percent
- Unknown
Recorded parties
Entities named on this deal record, each with the role it was recorded under.
- SponsorThe Blackstone GroupInvestment firm
- SponsorThe Carlyle GroupInvestment firm
- SponsorHellman & FriedmanInvestment firm
- Co-investorGIC Private LimitedInvestment firm
- TargetMedline Industries, Inc.Company
Record sources
Recorded provenance. These sources have not independently verified the deal fields or every party role.
- Blackstone, Carlyle and Hellman & Friedman to Invest in Medline
Medline Industries, Inc. · Published: June 5, 2021 · Retrieved: Aug. 29, 2026 · Recorded, not verified
About this record
Verified findings have passed evidence review and stay published only while their reviewed evidence matches what currently exists. Findings listed above are findings about this deal; they do not verify the deal’s other recorded fields.
Everything under Recorded deal, Recorded parties, and Recorded ownership is database record data. Record origin and independent verification are separate questions. Where a recorded field and a verified finding disagree, both are shown as they stand. Nothing here reconciles them.